Cerus Corp. (NASDAQ:CERS) saw an uptick in trading volume on Wednesday . 1,082,815 shares changed hands during trading, a decline of 3% from the previous session’s volume of 1,115,499 shares.The stock last traded at $6.48 and had previously closed at $6.30.

Several brokerages have recently commented on CERS. FBR & Co restated a “buy” rating on shares of Cerus Corp. in a research note on Monday, July 11th. Cantor Fitzgerald restated a “buy” rating and set a $9.00 price target on shares of Cerus Corp. in a research note on Thursday, July 7th. Robert W. Baird reaffirmed an “outperform” rating and set a $9.00 price objective on shares of Cerus Corp. in a research report on Wednesday, June 22nd. Finally, BTIG Research reaffirmed a “buy” rating and set a $10.00 price objective on shares of Cerus Corp. in a research report on Monday, June 20th. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $8.90.

The firm’s market capitalization is $670.78 million. The firm has a 50 day moving average of $6.13 and a 200 day moving average of $5.81.

Cerus Corp. (NASDAQ:CERS) last announced its quarterly earnings results on Tuesday, May 3rd. The company reported ($0.17) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.16) by $0.01. The firm earned $7.60 million during the quarter, compared to analyst estimates of $8.29 million. The firm’s revenue was down 1.3% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.17) earnings per share. On average, analysts forecast that Cerus Corp. will post ($0.65) EPS for the current year.

Several large investors have recently bought and sold shares of CERS. California State Teachers Retirement System increased its stake in Cerus Corp. by 1.8% in the fourth quarter. California State Teachers Retirement System now owns 176,709 shares of the company’s stock valued at $1,117,000 after buying an additional 3,126 shares in the last quarter. EAM Investors LLC purchased a new stake in Cerus Corp. during the fourth quarter valued at about $1,139,000. Rail Splitter Capital Management LLC increased its stake in Cerus Corp. by 19.0% in the fourth quarter. Rail Splitter Capital Management LLC now owns 832,722 shares of the company’s stock valued at $5,263,000 after buying an additional 132,970 shares in the last quarter. Stephens Inc. AR increased its stake in Cerus Corp. by 11.3% in the fourth quarter. Stephens Inc. AR now owns 1,112,665 shares of the company’s stock valued at $7,032,000 after buying an additional 113,238 shares in the last quarter. Finally, Wells Fargo & Company MN increased its stake in Cerus Corp. by 25.9% in the fourth quarter. Wells Fargo & Company MN now owns 4,901,666 shares of the company’s stock valued at $30,979,000 after buying an additional 1,007,430 shares in the last quarter.

Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company’s INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.